| GQJIX | VIHAX | GQJIX / VIHAX | |
| Total Expense Ratio | 0.59 | 0.16 | 369% |
| Annual Report Gross Expense Ratio | 0.66 | 0.16 | 413% |
| Fund Existence | 5 years | 10 years | - |
| Gain YTD | 10.515 | 17.601 | 60% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 500000 | 3000 | 16,667% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 678M | 21.9B | 3% |
| Annual Yield % from dividends | 3.62 | 3.45 | 105% |
| Returns for 1 year | 13.97 | 25.96 | 54% |
| Returns for 3 years | 64.93 | 75.63 | 86% |
| Returns for 5 years | 61.02 | 66.41 | 92% |
| Returns for 10 years | N/A | 108.07 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RMOCX | 19.25 | 0.23 | +1.21% |
| Victory RS Mid Cap Growth C | |||
| CIVHX | 22.29 | 0.17 | +0.77% |
| American Funds Intl Vntg 529-F-3 | |||
| GSYPX | 45.93 | 0.22 | +0.48% |
| Goldman Sachs Small Cap Value P | |||
| PASTX | 68.29 | 0.18 | +0.26% |
| T. Rowe Price Science & Tech Adv | |||
| JMNCX | 12.25 | -0.01 | -0.08% |
| JPMorgan Research Market Neutral C | |||